...
首页> 外文期刊>Majallah-i pizishki-i Urumiyah. >COMPARING GRAFT SURVIVAL AND PATIENT SURVIVAL RATE OF RENAL TRANSPLANTATION IN DIABETICPATIENTS,IN THE IMAM KHOMEINI HOSPITAL TRANSPLANTATION CENTER, URMIA,IRAN (2001-2011)
【24h】

COMPARING GRAFT SURVIVAL AND PATIENT SURVIVAL RATE OF RENAL TRANSPLANTATION IN DIABETICPATIENTS,IN THE IMAM KHOMEINI HOSPITAL TRANSPLANTATION CENTER, URMIA,IRAN (2001-2011)

机译:伊朗乌马阿马霍梅蒂尼医院移植中心的糖尿病患者中移植肾存活率和患者肾移植率的比较(2001-2011年)

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background & Aims : The aim of the present study was to compare graft survival and patient survival between diabetic and non-diabetic patients in the Imam Khomeini Hospital Transplant Center, during the years 2001 to 2011. Materials & Methods : This study was a retrospective cohort study. We used Kaplan-Meier test to calculate the patient and graft survival and t-test to compare continuous variables, Fisher exact test and x2 test to compare categorical data. Results: The mean duration of follow-up in patients with diabetes and nondiabetes was 37.09 ±53.15 and 34.49 ±62 months. five and 10 year patient survival rate among diabetic patients were 79 and 74.29%, while among non-diabetic patients were 89.28 and 81.01%, respectively. Five and 10 year graft survival rate among diabetic patients were 80 and 59.04%, respectively, and among non-diabetic patients were 84.35 and 77%. Conclusion : In this study, patient survival rate in diabetic and non-diabetics were significantly different (p=0/000), indicating the need for follow-up and ongoing management of diabetes after transplantation. There was no significant difference between graft survival rate in diabetic patients (p=0.243). The results showed transplantation is the best trapotic choice for diabetic patients.
机译:背景与目的:本研究的目的是比较2001年至2011年间伊玛目霍梅尼医院移植中心的糖尿病患者和非糖尿病患者的移植物存活率和患者存活率。材料与方法:这项研究是一项回顾性研究。研究。我们使用Kaplan-Meier检验计算患者和移植物存活率,使用t检验比较连续变量,使用Fisher精确检验和x2检验比较分类数据。结果:糖尿病和非糖尿病患者的平均随访时间为37.09±53.15和34.49±62个月。糖尿病患者的5年和10年生存率分别为79%和74.29%,而非糖尿病患者分别为89.28%和81.01%。糖尿病患者的五年和十年移植物存活率分别为80%和59.04%,非糖尿病患者为84.35%和77%。结论:在这项研究中,糖尿病患者和非糖尿病患者的生存率有显着差异(p = 0/000),表明在移植后需要随访和持续管理糖尿病。糖尿病患者的移植物存活率之间无显着差异(p = 0.243)。结果表明,移植是糖尿病患者的最佳选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号